ID   UG5LN
AC   CVCL_E7IT
WW   Provider; Inserm Transfert; RT00625; https://technology-offers.inserm-transfert.com/offer/ug5ln-cell-line/
CC   Population: Caucasian.
CC   Characteristics: Negative control cell line for measurement of nuclear receptor activity. Transfected with a (GAL4RE)5-betaGlobin-Luc-SV40-Neo construct where expression of the luciferase gene is driven by a pentamer of yeast activator GAL4-binding sites in front of beta-globin promoter (Inserm Transfert=RT00625).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Firefly luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//